BridgeMD
New treatment option for Refractive Errors
Official title Cognitive Level Enhancement Through Vision Exams and Refraction
ClinicalTrials.gov ID: NCT05458323
What this study is testing
- What it's testing
- The investigators aim to conduct a mixed-method study in which a randomised controlled trial (RCT) and a descriptive qualitative study will be conducted. The RCT aims to determine whether free near and distance glasses provided to residents in Hyderabad, India, aged ≥ 60 years, with under- or un- corrected refractive error and normal baseline hearing and cognition (HMSE \> 18), can improve quality of life, reduce falls, reduce depression, improve social interaction and physical activity cost-effectively over 36 months.
- Time commitment: about 36 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Community dwelling
- Residency a. Participants must plan to reside in the local area for the study duration
- Presenting vision in the better eye due to uncorrected refractive error
- Impaired distance vision less than 6/18
- Near vision less than N6 at 40 cm
You likely can't join if
- Impaired baseline cognition a. HMSE score less than or equal to 18
- Non-refractive causes of vision impairment
- Severely impaired mobility
- immobile
- bedridden
- wheelchair
See the full eligibility criteria
- Community dwelling
- Residency a. Participants must plan to reside in the local area for the study duration
- Presenting vision in the better eye due to uncorrected refractive error
- Impaired distance vision less than 6/18
- Near vision less than N6 at 40 cm
- Willingness
- to participate
- to be assigned by chance
- to adhere to the protocol
- Impaired baseline cognition a. HMSE score less than or equal to 18
- Non-refractive causes of vision impairment
- Severely impaired mobility
- immobile
- bedridden
- wheelchair
- using walker
- Severe medical illness likely to limit the life span
- Cancer
- Heart disease
- Stroke
- HIV or AIDS
- Chronic lung disease
- Kidney disease
- Hearing loss assessment
- self-reported hearing impairment
- inability to hear
- fail in whisper test hearing screening(unable to repeat three out of six words)
The study team makes the final eligibility decision.
Where it's taking place
- Hyderabad, Telangana, India
Compensation & support
Some study costs may be covered.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 36 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hyderabad, Telangana, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.